Plans for a controversial U.S.-funded hepatitis B vaccine study in Guinea-Bissau have been paused pending further review from national authorities.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results